Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 875.90M P/E - EPS this Y 7.80% Ern Qtrly Grth -
Income -97.22M Forward P/E -11.66 EPS next Y 78.00% 50D Avg Chg -9.00%
Sales - PEG -0.11 EPS past 5Y 58.11% 200D Avg Chg -25.00%
Dividend N/A Price/Book 4.29 EPS next 5Y 83.80% 52W High Chg -59.00%
Recommedations 2.00 Quick Ratio 8.60 Shares Outstanding 43.25M 52W Low Chg 25.00%
Insider Own 7.18% ROA -34.27% Shares Float 40.20M Beta -0.40
Inst Own 32.65% ROE -53.27% Shares Shorted/Prior 12.84M/11.96M Price 20.98
Gross Margin - Profit Margin - Avg. Volume 840,450 Target Price -
Oper. Margin - Earnings Date Apr 29 Volume 525,756 Change -3.94%
About Cassava Sciences, Inc.

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

Cassava Sciences, Inc. News
04/15/24 Redemption Date Announced for Warrants
08:13 AM Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
03/06/24 Bullish Cassava Sciences Insiders Loaded Up On US$3.12m Of Stock
03/04/24 Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference
02/28/24 Cassava Sciences Inc (SAVA) Reports Full-Year 2023 Financial Results
02/28/24 Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates
02/21/24 Exit Now! 3 Biotech Stocks to Sell in February 2024
02/07/24 No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months
02/05/24 Cassava Sciences, Inc. (NASDAQ:SAVA) most popular amongst retail investors who own 59% of the shares, institutions hold 31%
02/03/24 Is There Any Hope for Cassava Sciences Stock?
05:29 PM 3 Biotech Stocks to Sell in January Before They Crash and Burn
01/16/24 Cassava Sciences Stock Continues Showing Rising Relative Strength
01/05/24 Cassava Sciences Completes Dividend Distribution of Warrants to Shareholders
12/26/23 3 Growth Stocks Expected to Skyrocket in 2024, According to Wall Street
12/20/23 Companies Like Cassava Sciences (NASDAQ:SAVA) Are In A Position To Invest In Growth
12/15/23 Why Cassava Sciences Stock Zoomed 21% Higher This Week
12/13/23 Cassava Sciences Stock Shows Rising Relative Strength Following 3 Up Days
12/12/23 Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders
12/08/23 Why Cassava Sciences Stock Soared Today
12/07/23 Cassava Sciences Appoints Three New Members to its Board of Directors
SAVA Chatroom

User Image Shortsmasher23 Posted - 3 hours ago

$SAVA the shorts will have a heads up whenever big new come where they need to cover...I'm expecting a drop before shareholder meeting to make remi look

User Image pi828 Posted - 4 hours ago

$SAVA I believe we have a blockbuster drug. The question is can Remi monetize it with a BP company. He can't sell or partner it cheaply.

User Image Simufilam1 Posted - 5 hours ago

@bankswapsmarket $SAVA In Q4 they should have the only effective treatment for AD in the world. They will be valued according to forward revenue and not low balled. You would expect them to be swarmed by BP execs trying to cut a deal. BP has a patent shelf right now so M&A seems reasonable.

User Image Jimbo0119 Posted - 6 hours ago

$SAVA they just killing options this week

User Image History101 Posted - 6 hours ago

$SAVA short interest, per Barron's, 4/15/2024: 12.84MM shares short (up 8.95% from 3/28/2024): 32.0% of float 17.7 days to cover

User Image Kryticlthnkng Posted - 7 hours ago

$SAVA Warrants were distributed 1/3/24 -- 78 trading days ago. Days above $22(45), above $23(35), $24(24), $25(14), $26(8) - 58% of the time the share price has been above the economic redemption threshold ($22/share). Days below $22(33), $21(21), $20(9), $19(2) - 42% of the time the share price was below the threshold that would incent redemption. Average SAVA closing share price over that interval $22.72. Mar 2023 R Barry purchased 88K shares at roughly $26. 2022, S Robertson purchased 100K shares at roughly $21. A few observations: (1) economic price incentive to redeem existed over half the active warrant window and (2) key large shareholding insiders did not purchase additional shares which could improve their cost position (obviously recognizing that there have been other similar past windows of low share price opportunity). Continued in the reply.

User Image Twit_Ripper Posted - 8 hours ago

$SAVA https://finance.yahoo.com/news/bullish-cassava-sciences-insiders-loaded-102534241.html

User Image calbucs Posted - 10 hours ago

$SAVA Relentless Shorting by these crooks ! Let’s go Remi , we need to burn this trash in a bonfire . Almost 13 mill shares short and over 1 mill increase in the last 15 days yet they have not been able to bring it further down . Either submit for approval or Partnership!

User Image bankswapsmarket Posted - 12 hours ago

$SAVA Remi be smart sell the company for $150 to $250 be reasonable and move on… they will try to destroy you otherwise don’t be a fool … I have been long for 3+ years the market it is rigged BP ..market makers ….few other companies and banks, Gary. Gensler is a tool of corruption all in cahoots… the naked short everywhere and never cover… it’s sick watching what they did today to Immunity Bio it is hideous. Sick they are completely naked and they don’t care why cause the SEC is a joke and the control DTC and everything else.

User Image pi828 Posted - 12 hours ago

$SAVA give me another example of a 3 and a half month warrant life? Have to wonder if Remi is capable of getting the stock to 500 dollars by end of 2025? He definitely screwed retail investors who had faith in him and bought $SAVAW . The company is sitting on a blockbuster drug. I have my doubts about management's ability to get us to the promised land without screwing it up.

User Image zimzimrs Posted - 14 hours ago

$SAVA No Decline in Cognition Scores in Mild AD Over 24 Months From Feb 7, 2024, Press Release1 1 For detailed information, study limitations and forward-looking statements regarding this study, please see press release dated Feb 7, 2024 at www.CassavaSciences.com. • Patients with mild Alzheimer’s disease who received simufilam treatment continuously for two years (n=47) had no decline in ADAS-Cog scores (± 1.51 SE) as a group. • Patients with mild Alzheimer’s who received simufilam treatment non-continuously (n=40) declined 1 point on ADAS-Cog (± 1.65 SE) as a group. Non-continuous treatment consisted of one year on open-label drug, six months on placebo and six months back on open-label drug

User Image zimzimrs Posted - 14 hours ago

$SAVA https://www.cassavasciences.com/static-files/2e5fa90d-4e73-4b96-8d19-57edabe08130

User Image Ray_Ray Posted - 17 hours ago

$SAVA https://justthenews.com/government/congress/truth-social-ceo-calls-house-investigate-potential-unlawful-manipulation-djt

User Image Protof Posted - 17 hours ago

$SAVA as simple as betting on sports $20 50 to 1 = easy play.

User Image WallStreetBuyDip Posted - 17 hours ago

I compiled my previous 4 plays to show visually how crucial to know what H% is when making a trade. Many buy random levels $SAVA are you the type to trade momentum or the type to buy the dip for a reversal trade? Will trade W like how I did for these tickers shown here. These only show 4 trades of 100+ others The key is to buy when H% is low for a reversal trade. Review the Step-by-Step on chart.

User Image Protof Posted - 17 hours ago

$SAVA welp at this point every $20 I get I put in SAVA😂 yolo

User Image Twit_Ripper Posted - 18 hours ago

$SAVA and she goes green.. :)

User Image DaKine5 Posted - 18 hours ago

$SAVA I've been holding for 3 years, certainly not giving up now. It's coming!!

User Image InStock Posted - 18 hours ago

$SAVA only holding a small position but decided to double down today. Seems promising despite the recent controversy - I have a good feeling about this.

User Image potato12396737 Posted - 18 hours ago

$SAVA if this doesn’t rocket after warrant expiration, I’m loading the boat with 5/17 35c for 0.03. When it hits 0.04 ima buy a lambo

User Image Ben6288 Posted - 18 hours ago

$SAVA I think we are about to see some action soon!

User Image Induraman Posted - 19 hours ago

$SAVA Got a call from fidelity asking me if I wanted to join the share lending program. Since I am mostly in funds other then Sava, I found it interesting they would call.

User Image SAVA_Idiot Posted - 19 hours ago

$SAVA Bought 5000 warrants, great deal!

User Image xolli Posted - 19 hours ago

$SAVA scam

User Image Blakestein Posted - 20 hours ago

@CryptoManiacInvestor $SAVA gonna make me rich besides this 🤓

User Image Cutlass Posted - 20 hours ago

$SAVA Bears still think they will find shares down here, too funny.....keep trying 🤣

User Image bigron8671 Posted - 20 hours ago

$SAVA

User Image bigron8671 Posted - 20 hours ago

$SAVA

User Image Ada94088 Posted - 22 hours ago

$SAVA I bought ALL the 2026 Jan $25 options this morning.

User Image JoeSpringer Posted - 22 hours ago

$TSLA Surges on Elon Optimism 10:30 am ET Stream Action: https://youtube.com/live/3zBos4ZBUV0 $ALB $NEO $RIVN $SAVA

Analyst Ratings
HC Wainwright & Co. Buy Mar 5, 24
HC Wainwright & Co. Buy Aug 8, 23
HC Wainwright & Co. Buy Jul 6, 23
HC Wainwright & Co. Buy May 11, 23
HC Wainwright & Co. Buy May 9, 23
HC Wainwright & Co. Buy Mar 6, 23
HC Wainwright & Co. Buy Jan 24, 23
B. Riley Securities Buy Aug 11, 22
B. Riley Securities Buy Jan 24, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
SCANNON PATRICK J MD PHD Director Director Jun 12 Option 0.95 1,000 950 1,000 06/12/23
BARBIER REMI President and CEO President and CEO May 24 Option 16.87 85,713 1,445,978 782,002 05/25/23
ROBERTSON SANFORD Director Director May 10 Option 17.64 9,284 163,770 856,851 05/10/23
BARBIER REMI President and CEO President and CEO Jun 06 Option 23.38 65,368 1,528,304 822,437 06/07/22
BARBIER REMI President and CEO President and CEO Apr 25 Option 8.63 49,460 426,840 376,112 04/25/22
GUSSIN ROBERT Z Director Director Mar 29 Option 21.95 7,470 163,966 12,434 03/29/22
ROBERTSON SANFORD Director Director Mar 25 Option 20.3 4,670 94,801 924,765 03/28/22